Neal Richard D, Pasterfield Diana, Wilkinson Clare, Hood Kerenza, Makin Matthew, Lawrence Helen
Cardiff University, North Wales Clinical School, UK.
BMC Fam Pract. 2008 Jan 30;9:9. doi: 10.1186/1471-2296-9-9.
There is no validated way of measuring diagnostic delay in cancer, especially covering patient and primary care delays. An instrument is needed in order to determine the effect of potential interventions to reduce delay and improve cancer morbidity and mortality.
Development of a postal questionnaire tool to measure patient and primary care time responses to key symptoms and signs. The pilot questionnaire was sent to 184 patients with suspected cancer.
The response rate was only 85/184 (46.2%). Anxiety was cited as one reason for this low response. Patients returning questionnaires were more likely to be women and more likely to be younger. 84/85 (98.8%) provided consent to access medical records, and questions regarding health profile, smoking and socio-economic profile were answered adequately. Outcome data on their cancer diagnosis was linked satisfactorily and the question about GP-initiated investigations was answered well. Estimated dates for symptom duration were preferred for patient delays, but exact dates were preferred for primary care delays; however there was a significant amount of missing data.
A more personal approach to the collection of data about the duration of symptoms in this group of people is needed other than a postal questionnaire. However elements of this piloted questionnaire are likely to figure strongly in future development and evaluation of this tool.
目前尚无经过验证的方法来衡量癌症诊断延迟情况,尤其是涵盖患者和初级医疗延迟。需要一种工具来确定潜在干预措施对减少延迟以及改善癌症发病率和死亡率的效果。
开发一种邮寄问卷调查工具,以衡量患者和初级医疗对关键症状和体征的时间反应。试点问卷被发送给184名疑似癌症患者。
回复率仅为85/184(46.2%)。焦虑被认为是回复率低的一个原因。返回问卷的患者更可能是女性且更年轻。84/85(98.8%)的患者同意查阅病历,关于健康状况、吸烟和社会经济状况的问题得到了充分回答。他们癌症诊断的结果数据关联良好,关于全科医生发起的调查问题回答得也不错。对于患者延迟,症状持续时间的估计日期更受青睐,但对于初级医疗延迟,确切日期更受青睐;然而存在大量缺失数据。
除了邮寄问卷外,需要采用更个性化的方法来收集这群人症状持续时间的数据。然而,该试点问卷的要素可能会在该工具未来的开发和评估中发挥重要作用。